Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: Definium Therapeutics Inc., 7 months.
Definium Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Definium Therapeutics Inc. June 11, 202699.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Insmed Incorporated | Option exercise | +82,280 | $13.67 | $1,124,768 |
| Aug 10, 2026 | Insmed Incorporated | Option exercise | +76,600 | $17.16 | $1,314,456 |
| Aug 10, 2026 | Insmed Incorporated | Option exercise | +80,970 | $30.46 | $2,466,346 |
| Aug 10, 2026 | Insmed Incorporated | Open-market sale | −239,850 | $133.27 | $31,964,810 |
| Jun 11, 2026 | Definium Therapeutics Inc. | Grant or award | +3,555 | — | — |
| Jun 3, 2026 | Insmed Incorporated | Open-market sale | −2,370 | $102.27 | $242,380 |
| May 13, 2026 | Insmed Incorporated | Open-market sale | −5,837 | $116.18 | $678,143 |
| Apr 1, 2026 | Insmed Incorporated | Option exercise | +88,060 | $14.56 | $1,282,154 |
| Apr 1, 2026 | Insmed Incorporated | Open-market sale | −6,715 | $163.18 | $1,095,754 |
| Apr 1, 2026 | Insmed Incorporated | Open-market sale | −19,001 | $164.11 | $3,118,254 |
| Apr 1, 2026 | Insmed Incorporated | Open-market sale | −62,344 | $164.95 | $10,283,643 |
| Feb 3, 2026 | Insmed Incorporated | Open-market sale | −791 | $156.17 | $123,530 |
| Jan 8, 2026 | Insmed Incorporated | Open-market sale | −2,059 | $174.17 | $358,616 |
| Jan 7, 2026 | Insmed Incorporated | Open-market sale | −802 | $175.07 | $140,406 |
| Jan 6, 2026 | Insmed Incorporated | Open-market sale | −1,429 | $173.33 | $247,689 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.